» Articles » PMID: 36650007

Negative Impact of the Pandemic on Hospital Admissions, Morbidity and Early Mortality for Acute Cirrhosis Decompensation

Overview
Specialty Gastroenterology
Date 2023 Jan 17
PMID 36650007
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The global pandemic has diverted resources away from management of chronic diseases, including cirrhosis. While there is increasing knowledge on COVID-19 infection in liver cirrhosis, little is described on the impact of the pandemic on decompensated cirrhosis admissions and outcomes, which was the aim of this study.

Methods: A single-centre, retrospective study, evaluated decompensated cirrhosis admissions to a tertiary London hepatology and transplantation centre, from October 2018 to February 2021. Patients were included if they had an admission with cirrhosis decompensation defined as new-onset jaundice or ascites, infection, encephalopathy, portal hypertensive bleeding or renal dysfunction.

Results: The average number of admissions stayed constant between the pre-COVID-19 (October 2018-February 2020) and COVID-19 periods (March 2020-February 2021). Patients transferred in from secondary centres had consistently higher severity scores during the COVID-19 period (UK Model for End-Stage Liver Disease 58 vs 54; p=0.007, Model for End-Stage Liver Disease-Sodium 22 vs 18; p=0.006, EF-CLIF Acute Decompensation (AD) score 55.0 vs 51.0; p=0.055). Of those admitted to the intensive care without acute-on-chronic liver failure, there was a significant increase in AD scores during the COVID-19 period (58 vs 48, p=0.009). In addition, there was a trend towards increased hospital readmission rates during the COVID-19 period (29.5% vs 21.5%, p=0.067). When censored at 30 days, early mortality postdischarge was significantly higher during the COVID-19 period (p<0.001) with a median time to death of 35 days compared with 62 days pre-COVID-19.

Discussion: This study provides a unique perspective on the impact that the global pandemic had on decompensated cirrhosis admissions. The findings of increased early mortality and readmissions, and higher AD scores on ICU admission, highlight the need to maintain resourcing for high-level hepatology care and follow-up, in spite of other disease pressures.

Citing Articles

Evaluating Disparities in COVID-19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe-An International Registry Study.

Hayat U, Moon A, Gangwani M, Hasan F, Marjot T, Barritt 4th A JGH Open. 2024; 8(12):e70064.

PMID: 39618959 PMC: 11605158. DOI: 10.1002/jgh3.70064.


Association between alcohol-associated cirrhosis and inpatient complications among COVID-19 patients: A propensity-matched analysis from the United States.

Inayat F, Ali H, Patel P, Dhillon R, Afzal A, Rehman A World J Virol. 2023; 12(4):221-232.

PMID: 37970569 PMC: 10642379. DOI: 10.5501/wjv.v12.i4.221.

References
1.
Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J . Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013; 144(7):1426-37, 1437.e1-9. DOI: 10.1053/j.gastro.2013.02.042. View

2.
Davoren M, Demant J, Shiely F, Perry I . Alcohol consumption among university students in Ireland and the United Kingdom from 2002 to 2014: a systematic review. BMC Public Health. 2016; 16:173. PMC: 4759952. DOI: 10.1186/s12889-016-2843-1. View

3.
Garrido I, Liberal R, Gaspar R, Macedo G . Cirrhosis management in a major referral center during COVID-19. JHEP Rep. 2020; 2(5):100146. PMC: 7362857. DOI: 10.1016/j.jhepr.2020.100146. View

4.
Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C . The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol. 2020; 73(4):842-854. DOI: 10.1016/j.jhep.2020.06.013. View

5.
Mahmud N, Hubbard R, Kaplan D, Serper M . Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort Study. Gastroenterology. 2020; 159(3):1134-1136.e3. PMC: 7200325. DOI: 10.1053/j.gastro.2020.05.005. View